Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erzsébet Ravasz Regan is active.

Publication


Featured researches published by Erzsébet Ravasz Regan.


Circulation Research | 2012

Dynamical Systems Approach to Endothelial Heterogeneity

Erzsébet Ravasz Regan; William C. Aird

Endothelial cells display remarkable phenotypic heterogeneity. An important goal is to elucidate the scope and mechanisms of endothelial heterogeneity and to use this information to develop vascular bed–specific therapies. We reexamine our current understanding of the molecular basis of endothelial heterogeneity. We introduce multistability as a new explanatory framework in vascular biology. We draw on the field of nonlinear dynamics to propose a dynamical systems framework for modeling multistability and its derivative properties, including robustness, memory, and plasticity. Our perspective allows for both a conceptual and quantitative description of system-level features of endothelial regulation.


Cancer Research | 2014

AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer

Carmen Priolo; Saumyadipta Pyne; Joshua Rose; Erzsébet Ravasz Regan; Giorgia Zadra; Cornelia Photopoulos; Stefano Cacciatore; Denise Schultz; Natalia Scaglia; Jonathan E. McDunn; Angelo M. De Marzo; Massimo Loda

Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor pathways that affect their metabolism, or by activating metabolic pathways de novo with targeted mutations in critical metabolic enzymes. It is unknown whether human prostate tumors develop a similar metabolic response to different oncogenic drivers or a particular oncogenic event results in its own metabolic reprogramming. Akt and Myc are arguably the most prevalent driving oncogenes in prostate cancer. Mass spectrometry-based metabolite profiling was performed on immortalized human prostate epithelial cells transformed by AKT1 or MYC, transgenic mice driven by the same oncogenes under the control of a prostate-specific promoter, and human prostate specimens characterized for the expression and activation of these oncoproteins. Integrative analysis of these metabolomic datasets revealed that AKT1 activation was associated with accumulation of aerobic glycolysis metabolites, whereas MYC overexpression was associated with dysregulated lipid metabolism. Selected metabolites that differentially accumulated in the MYC-high versus AKT1-high tumors, or in normal versus tumor prostate tissue by untargeted metabolomics, were validated using absolute quantitation assays. Importantly, the AKT1/MYC status was independent of Gleason grade and pathologic staging. Our findings show how prostate tumors undergo a metabolic reprogramming that reflects their molecular phenotypes, with implications for the development of metabolic diagnostics and targeted therapeutics.


Nature Communications | 2016

A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity.

Lei Yuan; Gary C. Chan; David Beeler; Lauren Janes; Katherine Spokes; Harita Dharaneeswaran; Anahita Mojiri; William J. Adams; Tracey E. Sciuto; Guillermo García-Cardeña; Grietje Molema; Peter M. Kang; Nadia Jahroudi; Philip A. Marsden; Ann M. Dvorak; Erzsébet Ravasz Regan; William C. Aird

Previous studies have shown that biological noise may drive dynamic phenotypic mosaicism in isogenic unicellular organisms. However, there is no evidence for a similar mechanism operating in metazoans. Here we show that the endothelial-restricted gene, von Willebrand factor (VWF), is expressed in a mosaic pattern in the capillaries of many vascular beds and in the aorta. In capillaries, the mosaicism is dynamically regulated, with VWF switching between ON and OFF states during the lifetime of the animal. Clonal analysis of cultured endothelial cells reveals that dynamic mosaic heterogeneity is controlled by a low-barrier, noise-sensitive bistable switch that involves random transitions in the DNA methylation status of the VWF promoter. Finally, the hearts of VWF-null mice demonstrate an abnormal endothelial phenotype as well as cardiac dysfunction. Together, these findings suggest a novel stochastic phenotype switching strategy for adaptive homoeostasis in the adult vasculature.


Circulation Research | 2014

FoxO1-Mediated Activation of Akt Plays a Critical Role in Vascular Homeostasis

Harita Dharaneeswaran; Md. Ruhul Abid; Lei Yuan; Dylan Dupuis; David Beeler; Katherine Spokes; Lauren Janes; Tracey E. Sciuto; Peter M. Kang; Shou-Ching Jaminet; Ann M. Dvorak; Marianne A. Grant; Erzsébet Ravasz Regan; William C. Aird

Rationale: Forkhead box-O transcription factors (FOXOs) transduce a wide range of extracellular signals, resulting in changes in cell survival, cell cycle progression, and several cell type-specific responses. FOXO1 is expressed in many cell types, including endothelial cells (ECs). Previous studies have shown that Foxo1 knockout in mice results in embryonic lethality at E11 because of impaired vascular development. In contrast, somatic deletion of Foxo1 is associated with hyperproliferation of ECs. Thus, the precise role of FOXO1 in the endothelium remains enigmatic. Objective: To determine the effect of endothelial-specific knockout and overexpression of FOXO1 on vascular homeostasis. Methods and Results: We show that EC-specific disruption of Foxo1 in mice phenocopies the full knockout. Although endothelial expression of FOXO1 rescued otherwise Foxo1-null animals, overexpression of constitutively active FOXO1 resulted in increased EC size, occlusion of capillaries, elevated peripheral resistance, heart failure, and death. Knockdown of FOXO1 in ECs resulted in marked inhibition of basal and vascular endothelial growth factor–induced Akt-mammalian target of rapamycin complex 1 (mTORC1) signaling. Conclusions: Our findings suggest that in mice, endothelial expression of FOXO1 is both necessary and sufficient for embryonic development. Moreover, FOXO1-mediated feedback activation of Akt maintains growth factor responsive Akt/mTORC1 activity within a homeostatic range.


Blood | 2011

Vascular bed–specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle

Ju Liu; Lei Yuan; Grietje Molema; Erzsébet Ravasz Regan; Lauren Janes; David Beeler; Katherine Spokes; Yoshiaki Okada; Takashi Minami; Peter Oettgen; William C. Aird

A region of the human von Willebrand factor (VWF) gene between -2812 and the end of the first intron (termed vWF2) was previously shown to direct expression in the endothelium of capillaries and a subset of larger blood vessels in the heart and skeletal muscle. Here, our goal was to delineate the DNA sequences responsible for this effect. A series of constructs containing deletions or mutations of vWF2 coupled to LacZ were targeted to the Hprt locus of mice, and the resulting animals were analyzed for reporter gene expression. The findings demonstrate that DNA sequences between -843 and -620 are necessary for expression in capillary but not large vessel endothelium in heart and skeletal muscle. Further, expression of VWF in capillaries and larger vessels of both tissues required the presence of a native or heterologous intron. In vitro assays implicated a role for ERG-binding ETS motif at -56 in mediating basal expression of VWF. In Hprt-targeted mice, mutation of the ETS consensus motif resulted in loss of LacZ expression in the endothelium of the heart and skeletal muscle. Together, these data indicate that distinct DNA modules regulate vascular bed-specific expression of VWF.


Intensive Care Medicine | 2013

The flow dependency of Tie2 expression in endotoxemia

Neng F. Kurniati; Rianne M. Jongman; Franziska vom Hagen; Katherine Spokes; Jill Moser; Erzsébet Ravasz Regan; Guido Krenning; Jan-Renier A.J. Moonen; Martin C. Harmsen; Michel Struys; Hans-Peter Hammes; Jan G. Zijlstra; William C. Aird; Peter Heeringa; Grietje Molema; Matijs van Meurs

RationaleTie2 is predominantly expressed by endothelial cells and is involved in vascular integrity control during sepsis. Changes in Tie2 expression during sepsis development may contribute to microvascular dysfunction. Understanding the kinetics and molecular basis of these changes may assist in the development of therapeutic intervention to counteract microvascular dysfunction.ObjectiveTo investigate the molecular mechanisms underlying the changes in Tie2 expression upon lipopolysaccharide (LPS) challenge.Methods and resultsStudies were performed in LPS and pro-inflammatory cytokine challenged mice as well as in mice subjected to hemorrhagic shock, primary endothelial cells were used for in vitro experiments in static and flow conditions. Eight hours after LPS challenge, Tie2 mRNA loss was observed in all major organs, while loss of Tie2 protein was predominantly observed in lungs and kidneys, in the capillaries. A similar loss could be induced by secondary cytokines TNF-α and IL-1β. Ang2 protein administration did not affect Tie2 protein expression nor was Tie2 protein rescued in LPS-challenged Ang2-deficient mice, excluding a major role for Ang2 in Tie2 down regulation. In vitro, endothelial loss of Tie2 was observed upon lowering of shear stress, not upon LPS and TNF-α stimulation, suggesting that inflammation related haemodynamic changes play a major role in loss of Tie2 in vivo, as also hemorrhagic shock induced Tie2 mRNA loss. In vitro, this loss was partially counteracted by pre-incubation with a pharmacologically NF-кB inhibitor (BAY11-7082), an effect further substantiated in vivo by pre-treatment of mice with the NF-кB inhibitor prior to the inflammatory challenge.ConclusionsMicrovascular bed specific loss of Tie2 mRNA and protein in vivo upon LPS, TNFα, IL-1β challenge, as well as in response to hemorrhagic shock, is likely an indirect effect caused by a change in endothelial shear stress. This loss of Tie2 mRNA, but not Tie2 protein, induced by TNFα exposure was shown to be controlled by NF-кB signaling. Drugs aiming at restoring vascular integrity in sepsis could focus on preventing the Tie2 loss.


Blood | 2009

Differential roles for ETS, CREB and EGR binding sites in mediating VEGF receptor 1 expression in vivo

Enjing Jin; Ju Liu; Jun-ichi Suehiro; Lei Yuan; Yoshiaki Okada; Vesna Nikolova-Krstevski; Kiichiro Yano; Lauren Janes; David Beeler; Katherine Spokes; Dan Li; Erzsébet Ravasz Regan; Shou-Ching Shih; Peter Oettgen; Takashi Minami; William C. Aird

Vascular endothelial growth factor receptor 1 (VEGFR1) is a marker for endothelial-specific gene expression. We previously reported that the human VEGFR1 promoter (between -748 and +284) contains information for expression in the intact endothelium of transgenic mice. The objective of this study was to dissect the cis-regulatory elements underlying VEGFR1 promoter activity in vitro and in vivo. In primary endothelial cells, binding sites for E74-like factor 1 (ELF-1; between -49 and -52), cyclic adenosine monophosphate response element binding (CREB; between -74 and -81), and early growth response factor 1/3 (EGR-1/3; between -16 to -25) were shown to play a positive role in gene transcription, whereas a putative E26 transformation-specificsequence (ETS) motif between -36 and -39 had a net negative effect on promoter activity. When targeted to the Hprt locus of mice, mutations of the ELF-1 binding site and the CRE element reduced promoter activity in the embryonic vasculature and resulted in a virtual loss of expression in adult endothelium. Postnatally, the EGR binding site mutant displayed significantly reduced promoter activity in a subset of vascular beds. In contrast, mutation of the -39 ETS site resulted in increased LacZ staining in multiple vascular beds. Together, these results provide new insights into the transcriptional regulatory mechanisms of VEGFR1.


Developmental Cell | 2014

Do endothelial cells dream of eclectic shape

Katie Bentley; Andrew Philippides; Erzsébet Ravasz Regan

Endothelial cells (ECs) exhibit dramatic plasticity of form at the single- and collective-cell level during new vessel growth, adult vascular homeostasis, and pathology. Understanding how, when, and why individual ECs coordinate decisions to change shape, in relation to the myriad of dynamic environmental signals, is key to understanding normal and pathological blood vessel behavior. However, this is a complex spatial and temporal problem. In this review we show that the multidisciplinary field of Adaptive Systems offers a refreshing perspective, common biological language, and straightforward toolkit that cell biologists can use to untangle the complexity of dynamic, morphogenetic systems.


New Journal of Physics | 2014

Community detection by graph Voronoi diagrams

Dávid Deritei; Zsolt I. Lazar; István Papp; Róbert Sumi; Levente Varga; Erzsébet Ravasz Regan; Mária Ercsey-Ravasz

Accurate and efficient community detection in networks is a key challenge for complex network theory and its applications. The problem is analogous to cluster analysis in data mining, a field rich in metric space-based methods. Common to these methods is a geometric, distance-based definition of clusters or communities. Here we propose a new geometric approach to graph community detection based on graph Voronoi diagrams. Our method serves as proof of principle that the definition of appropriate distance metrics on graphs can bring a rich set of metric space-based clustering methods to network science. We employ a simple edge metric that reflects the intra- or inter-community character of edges, and a graph density-based rule to identify seed nodes of Voronoi cells. Our algorithm outperforms most network community detection methods applicable to large networks on benchmark as well as real-world networks. In addition to offering a computationally efficient alternative for community detection, our method opens new avenues for adapting a wide range of data mining algorithms to complex networks from the class of centroid- and density-based clustering methods.


Journal of Immunology | 2016

Intracellular RIG-I Signaling Regulates TLR4-Independent Endothelial Inflammatory Responses to Endotoxin

Jill Moser; Peter Heeringa; Rianne M. Jongman; Peter J. Zwiers; Anita E. Niemarkt; Rui Yan; Inge A. M. de Graaf; Ranran Li; Erzsébet Ravasz Regan; Philipp Kuempers; William C. Aird; Geerten P. van Nieuw Amerongen; Jan G. Zijlstra; Grietje Molema; Matijs van Meurs

Sepsis is a systemic inflammatory response to infections associated with organ failure that is the most frequent cause of death in hospitalized patients. Exaggerated endothelial activation, altered blood flow, vascular leakage, and other disturbances synergistically contribute to sepsis-induced organ failure. The underlying signaling events associated with endothelial proinflammatory activation are not well understood, yet they likely consist of molecular pathways that act in an endothelium-specific manner. We found that LPS, a critical factor in the pathogenesis of sepsis, is internalized by endothelial cells, leading to intracellular signaling without the need for priming as found recently in immune cells. By identifying a novel role for retinoic acid–inducible gene-I (RIG-I) as a central regulator of endothelial activation functioning independent of TLR4, we provide evidence that the current paradigm of TLR4 solely being responsible for LPS-mediated endothelial responses is incomplete. RIG-I, as well as the adaptor protein mitochondrial antiviral signaling protein, regulates NF-κB–mediated induction of adhesion molecules and proinflammatory cytokine expression in response to LPS. Our findings provide essential new insights into the proinflammatory signaling pathways in endothelial cells and suggest that combined endothelial-specific inhibition of RIG-I and TLR4 will provide protection from aberrant endothelial responses associated with sepsis.

Collaboration


Dive into the Erzsébet Ravasz Regan's collaboration.

Top Co-Authors

Avatar

William C. Aird

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

David Beeler

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Katherine Spokes

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lei Yuan

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Grietje Molema

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Ann M. Dvorak

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Tracey E. Sciuto

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge